Tumor cells display phenotypic plasticity and heterogeneity due to genetic and epigenetic variations which limit the predictability of therapeutic interventions. Chromatin modifications can arise stochastically but can also be a consequence of environmental influences such as the microenvironment of cancer cells. A better understanding of the impact and dynamics of epigenetic modulation at defined chromosomal sites is required to get access to the underlying mechanisms. We investigated the epigenetic modulations leading to cell-to-cell heterogeneity in a tumor cell line model. To this end, we analyzed expression variance in 80 genetically uniform cell populations having a single-copy reporter randomly integrated in the genome. Single-cell a...
Abstract Background Cell-to-ce...
During cancer progression, tumor cells undergo various molecular and phenotypic changes collectively...
International audienceMalignant cell transformation could be considered as a series of cell reprogra...
tIntraclonal heterogeneity of genetically modified mammalian cells has been observed as a phenomenon...
Both genetic and epigenetic changes drive cancer progression. Current work in the field of epigeneti...
In this Perspective, we synthesize past and present observations in the field of epigenetics to prop...
Cancer is a group of heterogeneous diseases that results from the occurrence of genetic alterations ...
The human body is a patchwork of tissues working collectively to maintain homeostasis and achieve fi...
Epigenetic and transcriptional variability contribute to the vast diversity of cellular and organism...
International audienceFor decades, most of molecular biology was driven by the "central dogma" in wh...
Epigenetic and transcriptional variability contribute to the vast diversity of cellular and organism...
SummaryHuman embryonic stem cells (hESCs) share an identical genome with lineage-committed cells, ye...
Tumor heterogeneity poses one of the greatest challenges to a successful treatment of cancer. Tumor ...
Intratumor genetic heterogeneity (ITH) is the main obstacle to effective cancer treatment and a majo...
Cancer is a disease potentiated by mutations in somatic cells. Cancer mutations are not distributed ...
Abstract Background Cell-to-ce...
During cancer progression, tumor cells undergo various molecular and phenotypic changes collectively...
International audienceMalignant cell transformation could be considered as a series of cell reprogra...
tIntraclonal heterogeneity of genetically modified mammalian cells has been observed as a phenomenon...
Both genetic and epigenetic changes drive cancer progression. Current work in the field of epigeneti...
In this Perspective, we synthesize past and present observations in the field of epigenetics to prop...
Cancer is a group of heterogeneous diseases that results from the occurrence of genetic alterations ...
The human body is a patchwork of tissues working collectively to maintain homeostasis and achieve fi...
Epigenetic and transcriptional variability contribute to the vast diversity of cellular and organism...
International audienceFor decades, most of molecular biology was driven by the "central dogma" in wh...
Epigenetic and transcriptional variability contribute to the vast diversity of cellular and organism...
SummaryHuman embryonic stem cells (hESCs) share an identical genome with lineage-committed cells, ye...
Tumor heterogeneity poses one of the greatest challenges to a successful treatment of cancer. Tumor ...
Intratumor genetic heterogeneity (ITH) is the main obstacle to effective cancer treatment and a majo...
Cancer is a disease potentiated by mutations in somatic cells. Cancer mutations are not distributed ...
Abstract Background Cell-to-ce...
During cancer progression, tumor cells undergo various molecular and phenotypic changes collectively...
International audienceMalignant cell transformation could be considered as a series of cell reprogra...